- Home
- OGE vs VRNA Comparison
OGE vs VRNA Comparison
Compare OGE & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGE
- VRNA
- Stock Information
- Founded
- OGE 1902
- VRNA 2005
- Country
- OGE United States
- VRNA United Kingdom
- Employees
- OGE N/A
- VRNA N/A
- Industry
- OGE Electric Utilities: Central
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- OGE Utilities
- VRNA Health Care
- Exchange
- OGE Nasdaq
- VRNA Nasdaq
- Market Cap
- OGE 8.9B
- VRNA 8.3B
- IPO Year
- OGE N/A
- VRNA 2017
- Fundamental
- Price
- OGE $45.63
- VRNA $105.20
- Analyst Decision
- OGE Strong Buy
- VRNA Buy
- Analyst Count
- OGE 5
- VRNA 11
- Target Price
- OGE $46.80
- VRNA $114.10
- AVG Volume (30 Days)
- OGE 1.0M
- VRNA 2.3M
- Earning Date
- OGE 07-30-2025
- VRNA 08-06-2025
- Dividend Yield
- OGE 3.69%
- VRNA N/A
- EPS Growth
- OGE 19.03
- VRNA N/A
- EPS
- OGE 2.43
- VRNA N/A
- Revenue
- OGE $3,215,200,000.00
- VRNA $221,673,000.00
- Revenue This Year
- OGE $8.33
- VRNA $895.44
- Revenue Next Year
- OGE $4.61
- VRNA $77.76
- P/E Ratio
- OGE $18.80
- VRNA N/A
- Revenue Growth
- OGE 16.01
- VRNA N/A
- 52 Week Low
- OGE $38.86
- VRNA $23.79
- 52 Week High
- OGE $46.91
- VRNA $105.50
- Technical
- Relative Strength Index (RSI)
- OGE 56.81
- VRNA 68.80
- Support Level
- OGE $44.58
- VRNA $105.16
- Resistance Level
- OGE $46.12
- VRNA $105.46
- Average True Range (ATR)
- OGE 0.69
- VRNA 0.24
- MACD
- OGE -0.00
- VRNA -0.67
- Stochastic Oscillator
- OGE 73.93
- VRNA 43.40
About OGE OGE Energy Corp
OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution to 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.